Pradaxa Lawsuit News and Information
The new blood thinner Pradaxa has been linked to an increased risk of serious and potentially life-threatening bleeding, leading many to question its safety. PRADAXA LAWSUIT STATUS: Users of Pradaxa who suffered severe internal bleeding, hemorrhages or other problems may be eligible to pursue a Pradaxa lawsuit. Lawyers are reviewing potential claims for individuals throughout […]
All Articles Tagged With: "Pradaxa"
A recent report highlights the growing trend in Xarelto injuries and shows how the FDA may be underestimating the side effects of some drugs.
The makers of the blood thinner Pradaxa have received breakthrough status to speed up the development of a potential antidote to prevent Pradaxa bleeding injuries and deaths.
UK health officials are recommending increased use of Pradaxa and Xarelto, despite the potential bleeding risks.
A growing number of Xarelto lawsuits are being filed over bleeding risks associated with the anticoagulant.
The FDA has launched a new open-access database for its drug adverse event reports, which it says is the first step in greater transparency.
The makers of Pradaxa and plaintiffs’ attorneys have reached a $650 million settlement to resolve about 4,000 product liability claims.
A federal judge is trying to get both sides to forge a settlement agreement that could prevent thousands of Pradaxa lawsuits from going to trial.
Boehringer Ingelheim has found more inconsistencies with the RE-LY trial that led to Pradaxa’s approval, but continues to stand behind the study’s results.
Adverse event reports involving Xarelto over the last year exceed those with Pradaxa, as the drug rises in popularity.
The FDA warns that the blood thinner Pradaxa appears more likely to cause gastrointestinal bleeding when compared to warfarin.
Contact a LawyerSubmit information about your potential case to be reviewed by an attorney.